U.S. FDA says current COVID vaccines not 'well-matched' against BA.2 variant

Posted on
FILE PHOTO: A health care worker points to a man wearing a protective face mask while waiting in line to receive one of the available first, second and booster doses of the coronavirus disease (COVID-19) vaccine at the L.A. Care Health Plan free testing and vaccination site at the First African Episcopal Church in Los Angeles, California, U.S., January 29, 2022. REUTERS/Shannon Stapleton

(Reuters) – The U.S. Food and Drug Administration said on Wednesday that currently available COVID-19 vaccines are not well matched against the BA.2 sub-variant of Omicron, although booster doses help protect against severe outcomes.

The comments were made at a meeting of the FDA’s outside experts to discuss the timing of additional COVID-19 vaccine boosters and people eligible for extra shots.

Source: Read Full Article

Related posts:
  1. Cloud-based telehealth, linked with Epic EHR, helps one hospital scale up virtual care
  2. Couldn’t socially distance? Blame your working memory
  3. Some medical workers unsure about France's partial lockdown
  4. Lala Kent Shares 1st Pic of Her and Randall Emmett's Daughter Ocean's Face
  5. ‘Grave concern’ over Covid in Europe as German cases soar
Related posts